American Cannabis Company (OTCQB:AMMJ) announced two of its active clients applied for business licenses to operate in the medical cannabis landscape in Ohio.
As quoted in the press release:

One of the clients, located near central Ohio, initially retained ACC to complete project planning activities including regulatory review, a financial pro-forma model and a custom business plan. This client later contracted ACC to perform site conceptual design work as well as assist in the completion of the Level 1 Cultivator License Application for the State of Ohio.
The second client, located in the northern region of the state, has retained ACC to provide their project with end-to-end cannabusiness solutions, which include but are not limited to operational planning activities, conceptual design work, application completion, deployment of operations (cultivation, manufacturing/processing, dispensary) and ongoing remote management oversight. ACC expects to leverage this contract to secure additional revenues through long-term consulting agreements and potential future sales of ancillary products.
Terry Buffalo, CEO of American Cannabis Company, commented: “We are happy to be working with driven clients who want to see their businesses truly succeed. Our skilled project management team and motivated clients have produced, organized and finalized these application materials, and we feel that each of our clients in Ohio are prepared to flourish in this brand new market.”


Click here to read the full press release.

Source: www.marketwired.com

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less